Search for: "Pfizer Inc." Results 41 - 60 of 1,505
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jun 2023, 8:21 am by Mark Astarita
The Securities and Exchange Commission today announced insider trading charges against Amit Dagar, a former Pfizer Inc. employee, and his close friend and business partner, Atul Bhiwapurkar, for trading in advance of the company’s November 5, 2021,…Read the Full Press Release Have a securities law question? [read post]
20 Jun 2023, 5:55 am by Jennifer Papapanagiotou
Food and Drug Administration (FDA) issued two Emergency Use Authorizations (EUAs) for the Pfizer, Inc. and the ModernaTX, Inc. [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
16 Apr 2023, 9:40 pm by Patent Docs
Bauer, Retired, Medtronic, Inc.; Dean Harts of 3M Innovative Properties Co.; Sharon Reiche of Pfizer Inc.; and Bill Warren of Eversheds Sutherland, who were involved in the preparation of IPO's comments, will cover issues such as trade secret protection, counterfeiting, compulsory licenses, issues in IP enforcement, genetic resources and an overview of developments at multilateral organizations. [read post]
5 Apr 2023, 5:18 am by Annsley Merelle Ward
A similar situation arose a few years in Pfizer v Roche [2019] EWHC 1520 (Pat). [read post]
24 Feb 2023, 5:40 am by Robert Kraft
Reuters reports that the US Supreme Court “turned away Pfizer Inc’s bid to revive its plan to cover out-of-pocket expenses of Medicare patients for drugs costing $225,000 a year to treat a rare heart condition,” transthyretin amyloid cardiomyopathy, “after federal officials found that the drugmaker’s arrangement could amount to illegal kickbacks. [read post]
14 Feb 2023, 12:29 pm
</span> </p> <p> <span style="display: initial;"> <br/> </span> </p> <p> <span style="display: initial;"> <span style="display: initial;"> Famous trademark infringement </span> </span> <a href="https://www.business.com/articles/5-trademark-cases-and-what-you-should-learn-from-them/"… [read post]
1 Feb 2023, 9:05 pm by renholding
  Pfizer was a major contributor to the level of healthcare M&A, announcing a number of deals, including its $11.6 acquisition of Biohaven Pharmaceuticals, $5.4 billion acquisition of Global Blood Therapeutics and $525 million acquisition of ReViral. [read post]
3 Jan 2023, 1:47 pm by Kevin LaCroix
The directors’ and officers’ liability environment is always changing, but 2022 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
13 Dec 2022, 7:41 pm by Juvan Bonni
Duane Morris LLP Caterpillar Inc. [read post]
14 Nov 2022, 12:15 am
Food & Drug Administration, financial results, and an impending merger with a division of Pfizer Inc. [read post]
6 Oct 2022, 5:23 pm by Sabrina I. Pacifici
The study, led by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, aimed to define the clinical course and the immunologic and virologic characteristics of COVID-19 rebound in patients who have taken nirmatrelvir/ritonavir (Paxlovid), an antiviral therapeutic developed by Pfizer, Inc. [read post]
2 Sep 2022, 5:01 am by Eugene Volokh
This new article of mine will be coming out next year in the Journal of Law and Religion, and I thought I'd serialize it here; there's still plenty of time for editing, so I'd love to hear people's feedback. [read post]
31 Aug 2022, 8:51 pm by Patent Docs
Noonan -- On Friday, August 26th, Moderna Tx, Inc. and Moderna US, Inc. filed a complaint for patent infringement in Federal district court for the District of Massachusetts against Pfizer, Inc., BioNTech SE, BioNTech Manufacturing GmbH, and BioNTech US, Inc. [read post]